Effects of Docosahexaenoic Acid (DHA) on Heart Rate Variability in Elderly Patients

NCT00749307 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2009-11-25

No results posted yet for this study

Summary

The purpose of this study is to test the hypothesis that dietary supplementation with an algal source of docosahexaenoic acid (DHA) can improve the heart rate variability in elderly patients.

Conditions

Interventions

DIETARY_SUPPLEMENT

Docosahexaenoic acid (DHA)

DIETARY_SUPPLEMENT

Placebo

Sponsors & Collaborators

  • IRCCS San Raffaele

    collaborator OTHER
  • DSM Nutritional Products, Inc.

    collaborator INDUSTRY
  • Pharmanutra s.r.l.

    collaborator UNKNOWN
  • Campus Bio-Medico University

    lead OTHER

Principal Investigators

  • Raffaele Antonelli Incalzi, MD · Campus Bio-Medico University

  • Giuseppe Rosano, MD · IRCCS San Raffaele Pisana. Department of Medical Sciences. Cardiovascular Research Unit.

  • Francesco M Serino, MD · Campus Bio-Medico University

  • Marco Miceli, MD · IRCCS San Raffaele Pisana. Department of Sciences. Cardiovascular Research Unit.

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-06-30
Primary Completion
2009-09-30
Completion
2009-11-30

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00749307 on ClinicalTrials.gov